Add Reply
Add Comment As A Guest
Close Topic OptionsAstraZeneca
Astrazeneca - Psychology, Special Needs, Health - Posted: 19th May, 2014 - 2:09pm
Posts: 12 - Views: 1010
Pharmaceuticals
Post Date: 19th Dec, 2010 - 1:56pm / Post ID: #
NOTE: Informer [?]
AstraZeneca
AstraZeneca
Health / Medicine Related News
The US rejection of the Anglo-Swedish drugmaker's blood clot-reducing drug Bilinta is a blow for the industry
Source: FT.com - Pharmaceuticals
Sponsored Links:
Post Date: 15th Nov, 2011 - 4:30am / Post ID: #
NOTE: Informer [?]
AstraZeneca
Drug failure leaves AstraZeneca depressed
Pharmaceutical group misses out on FTSE rebound after tests showed promising new treatment had no clear benefit over a placebo
Source: FT.com - Pharmaceuticals
Post Date: 27th Mar, 2012 - 4:30am / Post ID: #
NOTE: Informer [?]
AstraZeneca Health & Special Psychology
AstraZeneca chiefs total pay surges
Bonuses and shares push David Brennans package to more than £9m, despite concerns over the future of the Anglo-Swedish pharmaceutical group
Source: Pharmaceuticals companies news from the Financial Times
Post Date: 24th Apr, 2012 - 4:30am / Post ID: #
NOTE: Informer [?]
AstraZeneca
AstraZeneca to pay $1.3bn for Ardea
The agreement to purchase the US biotechnology company seeks to secure future sales before patents for key medicines expire
Source: Pharmaceuticals companies news from the Financial Times
Post Date: 2nd Oct, 2012 - 4:30am / Post ID: #
NOTE: Informer [?]
AstraZeneca
AstraZenecas new chief suspends buybacks
Pascal Soriots action will retain the unspent $2.2bn from the companys $4.2bn buyback programme and help fund potential acquisitions
Source: Pharmaceuticals companies news from the Financial Times
Post Date: 19th Mar, 2013 - 4:30am / Post ID: #
NOTE: Informer [?]
AstraZeneca
AstraZeneca cuts 1600 jobs in UK and US
Pharma group to take $1.4bn charge as restructuring will see shift from Alderley Park to new research hub and global HQ in Cambridge
Source: Pharmaceuticals companies news from the Financial Times
Post Date: 26th Mar, 2013 - 4:30am / Post ID: #
NOTE: Informer [?]
AstraZeneca
AstraZeneca wins US drug patent case
Judgment defers cut-price competition on cholesterol drug Crestor with generic companies Actavis and Egis ordered to pay royalties until May 2016
Source: Pharmaceuticals companies news from the Financial Times
TOPIC: AstraZeneca